Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (s)-(2-chloro-4-fluoro-5-(7-morpholinoquinazolin-4-yl)phenyl)(6-methoxypyridazin-3-yl)methanol
2. M3814
3. Peposertib
1. Peposertib
2. 1637542-33-6
3. M3814
4. Msc2490484a
5. M-3814
6. Msc-2490484a
7. Gn429e725a
8. (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol
9. (s)-(2-chloro-4-fluoro-5-(7-morpholinoquinazolin-4-yl)phenyl)(6-methoxypyridazin-3-yl)methanol
10. Nedisertib [inn]
11. M-3814(nedisertib)
12. Peposertib [inn]
13. Nedisertib (deleted Inn)
14. Peposertib [who-dd]
15. Unii-gn429e725a
16. Gtpl9766
17. Chembl4297629
18. Schembl16235559
19. Bdbm315715
20. Ex-a1679
21. Mfcd31619234
22. Msc 2490484a
23. Nsc802822
24. Nsc816960
25. Us10172859, Example 136
26. Msc 2490484a [who-dd]
27. Nsc-802822
28. Nsc-816960
29. Example 136 [wo2014183850]
30. Hy-101570
31. Cs-0021723
32. 3-pyridazinemethanol, .alpha.-(2-chloro-4-fluoro-5-(7-(4-morpholinyl)-4-quinazolinyl)phenyl)-6-methoxy-, (.alpha.s)-
33. 3-pyridazinemethanol, Alpha-(2-chloro-4-fluoro-5-(7-(4-morpholinyl)-4-quinazolinyl)phenyl)-6-methoxy-, (alphas)-
| Molecular Weight | 481.9 g/mol |
|---|---|
| Molecular Formula | C24H21ClFN5O3 |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 481.1316954 g/mol |
| Monoisotopic Mass | 481.1316954 g/mol |
| Topological Polar Surface Area | 93.5 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 662 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
87
PharmaCompass offers a list of Peposertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Peposertib manufacturer or Peposertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Peposertib manufacturer or Peposertib supplier.
PharmaCompass also assists you with knowing the Peposertib API Price utilized in the formulation of products. Peposertib API Price is not always fixed or binding as the Peposertib Price is obtained through a variety of data sources. The Peposertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Peposertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Peposertib, including repackagers and relabelers. The FDA regulates Peposertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Peposertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Peposertib supplier is an individual or a company that provides Peposertib active pharmaceutical ingredient (API) or Peposertib finished formulations upon request. The Peposertib suppliers may include Peposertib API manufacturers, exporters, distributors and traders.
Peposertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Peposertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Peposertib GMP manufacturer or Peposertib GMP API supplier for your needs.
A Peposertib CoA (Certificate of Analysis) is a formal document that attests to Peposertib's compliance with Peposertib specifications and serves as a tool for batch-level quality control.
Peposertib CoA mostly includes findings from lab analyses of a specific batch. For each Peposertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Peposertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Peposertib EP), Peposertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Peposertib USP).
